Wang et al. found that circCNST promoted the tumorigenesis of osteosarcoma cells by sponging miR-421 and targeting SLC25A3, providing a potential biomarker for patients with osteosarcoma [12]. This evidence concerns the gene SLC25A3 and osteosarcoma.